|
AstraZeneca Pharma India Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
20271.25 Cr.
|
P/BV
|
23.23
|
Book Value (Rs.)
|
349.12
|
|
52 Week High/Low (Rs.)
|
9850/7552
|
FV/ML
|
2/1
|
P/E(X)
|
108.10
|
|
Bookclosure
|
31/07/2026
|
EPS (Rs.)
|
75.01
|
Div Yield (%)
|
0.44
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 2272.58 | 1713.29 | 1295.53 | 1002.97 | 805.60 |
| Other Operating Revenues | 3.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Total Operating Revenues | 2275.58 | 1716.29 | 1295.53 | 1002.97 | 805.60 |
| | | | | | |
| Other Income | 28.49 | 40.63 | 34.80 | 26.10 | 14.76 |
| Total Revenue | 2304.07 | 1756.92 | 1330.33 | 1029.07 | 820.36 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 9.49 | 287.13 | 129.02 | 84.38 | 89.61 |
| Purchase Of Stock-In Trade | 1859.42 | 1008.82 | 499.31 | 324.46 | 207.88 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -488.37 | -332.94 | -33.77 | -48.86 | 14.47 |
| Employee Benefit Expenses | 264.38 | 257.44 | 241.45 | 259.10 | 230.21 |
| Finance Costs | 4.49 | 1.46 | 1.20 | 0.63 | 0.95 |
| Depreciation And Amortisation Expenses | 28.58 | 39.99 | 14.94 | 16.26 | 16.95 |
| Other Expenses | 368.63 | 241.87 | 275.07 | 218.77 | 177.25 |
| Total Expenses | 2046.62 | 1503.77 | 1127.22 | 854.74 | 737.32 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 257.45 | 253.15 | 203.11 | 174.33 | 83.04 |
| | | | | | |
| Exceptional Items | -5.25 | -96.79 | 16.43 | -40.23 | 0.00 |
| Profit/Loss Before Tax | 252.20 | 156.36 | 219.54 | 134.10 | 83.04 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 59.14 | 60.10 | 53.55 | 38.30 | 22.63 |
| Deferred Tax | 5.26 | -19.92 | -0.90 | -3.49 | -1.19 |
| Tax For Earlier Years | 0.28 | 0.44 | 5.38 | 0.00 | 0.00 |
| Total Tax Expenses | 64.68 | 40.62 | 58.03 | 34.81 | 21.44 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 187.52 | 115.74 | 161.51 | 99.29 | 61.60 |
| | | | | | |
| Profit/Loss From Continuing Operations | 187.52 | 115.74 | 161.51 | 99.29 | 61.60 |
| | | | | | |
| Profit/Loss For The Period | 187.52 | 115.74 | 161.51 | 99.29 | 61.60 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 75.01 | 46.30 | 64.60 | 39.70 | 24.60 |
| Diluted EPS (Rs.) | 75.01 | 46.30 | 64.60 | 39.70 | 24.60 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 80.00 | 60.00 | 40.00 | 20.00 | 5.00 |
| Equity Dividend Rate (%) | 1800.00 | 1600.00 | 1200.00 | 800.00 | 500.00 |
